Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2024-06-30
Current total value of award: $30030.34
Description: DUX4 ANTIBODY PRODUCTION